Attention--this is one of the older files in the Peripheral Brain, mostly based on a lecture I heard as a resident in 1994. Take it with several grains of salt--ER 1/99
All listed below are IM & IV unless otherwise indicated:
1st Generation:
- These last 4 are therapeutic & pharmacokinetic equivalents)
- Coverage:
- Gram +: better than 2g/3g
- Staph: covers all except MRSA
- Strep: covers all except enterococci (S. Fecalis; Gp. D)
- Gram - rods:
- Covers E. Coli, Proteus Mirabilis (indole -), Neisseria sp., Salmonella, Shigella
- Not very good for Klebsiella or H. Influenza
- Not effective for Pseudomonas, Enterobacter, Serratia, or indole + Proteus
- Anaerobes:
- Good for gm + (supradiaphragmatic) anaerobes
- Not effective for Bacteroides fragilis
- Clinical use
- Alternative to PCN for Staph. & Strep.
- URIs, soft tissue inf. 2? to mixed flora
- UTIs
- Surg. prophylaxis
- Can use for Klebsiella along w/aminoglycoside
- Cefazolin is a good workhorse: cheap, effective, less frequent (TID) dosing, high pk lvl 2? to small Vd., more activity than Cephalothin against E. Coli, Klebsiella, less painful IM than Keflex
- But Cephalithin may be better than Cefazolin in inf. with ?-lactamase producing organisms, e.g. Staph endocarditis (more restistant to ?-lactamase)
- Both Cefazolin & Cephalothin are 70-80% protein-bound, eliminated un-G'd by kidneys, & don't penetrate CSF adequately for use in meningitis
- The PO's have excellent urine levels; good serum, tissue, bone, synovial fluid levels achieved when used in mod-hi dose
- Cefaclor
- More active against gm-'s, esp. H. Flu (inc. ampi-resistant) than cephalexin
- Used in otitis, URI; should reserve for bacteria resistant to ampi + bactrim
- Expensive
2nd generation:
Divided into 2 groups as above; all agents within a group essentially equivalent
Cefamandole group:
- Same gram + coverage as 1g's
- Possibly good for coag - Staph (better than PCN)
- Gram - same as 1g's plus indole + Proteus, H. flu. (so can use in comm.-acq'd pneumonia in COPD pts), some Citrobacter, Providencia, Enterobacter
- Anerobes same as 1g's
- (.75-1.5g)TID for cure; BID for surg. prophylaxis
- Good CNS penetration
- More resistant to Beta-lactamase-producing H. Flu than cefamandole--good for peds.
- Renally excreted; must adjust dose in RF
- QD-BID dosing
- Less Staph. coverage than others in this group
Cefoxitin group:
- Gram - aerobes: less than other group at H. flu., Enterobacter, Citrobacter, Providencia
- Gram - anaerobes: modest activity (1g's & other 2g's have none)
- Cheap
- BID dosing
- Better gram - coverage than Cefoxitin; same anaerobic activity
- Has MTTZ side ring which can PT; avoid if pt on Coumadin!
Cliinical use:
- 2nd line for community-acquired pneumonia, except for "high-risk" pts, e.g. CHF, COPD, EtOH
- Tx. of ampi-resistant H. flu (as above)
- CV-surg prophylaxis
- OB/GYN infections
- Diabetic foot infections
- Surg prophylaxis (OB/GYN, biliary)
- Formerly for intra-abdominal infections, but now too much resistance
3rd generation
Divided into 2 groups as above; all agents within a group essentially equivalent; other agents:
*3g's contraindicated in neonates (<10do) because displace bilirubin from serum proteins*
Cefotaxime group:
- Gram +: less for Staph than 1g/2g's; poor against Enterococci & MRSA
- Gram - aerobes: excellent for most except Pseudomonas, Listeria; excellent for Neisseria sp., H. Flu (inc. ?-lactamase producers)
- Anaerobes: poor activity
- QD dosing (1-2g) except in meningitis (2g Q12?)
- Cleared through kidneys & liver, so don't need to adjust dose in renal failure
- Theoretical risk of cholecystitis
- Drug of choice for gonorrhea (125-250 IM x 1)
- Both have renal excretion
- -taxime 1-2g Q6-8?; -zoxime 1-2g Q8?
Cefoperazone group:
- Same as cefotaxime group except:
- Anti- P. Aeruginosa activity, ceftaz>cefoperazone
- Biliary clearance; no adjustment of dose in RF
- BID dosing (2g Q12?)
- MTTZ side ring: can PT
- Disulfiram-like reaction
- Better CNS penetration than Cefoperazone
- Good against Acinetobacter
- Poor for gram +'s and anaerobes
- 1-2g Q8h
Cllinical use: